Comments on the Epsolay FDA Approval for Rosacea

Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama, sits down to talk the approval of the 5% encapsulated benzoyl peroxide (E-BPO) cream (Epsolay; Sol-Gel Technologies Ltd and Galderma) that was just recently approved for the treatment of inflammatory lesions of rosacea (papulopustular rosacea or PPR) in adult patients.

This long awaited drug approval is the first rosacea drug approved this year and Harper talks how it works, its potential as a first line treatment, and much more in this interview.